Expert: Bispecific antibody simultaneously targeting PD-1 and TIGIT immune checkpoints to enhance anti-tumor T-cell and NK-cell activity.
Everyday: A two-in-one antibody that removes two different brakes on the immune system to fight cancer.
Targets: ["PD-1","TIGIT"]